CIS Network Seminar: #HUG
“Data science for precision oncology”
Prof. Olivier Michielin, MD-PhD, Head of Department of Oncology and Precision Oncology Service, Geneva University Hospital
Monday Mar. 13, 2023 | 15:15-16:15 CET
Data science is revolutionising many fields of research. Its impact on the healthcare system is also rapidly growing, especially in the area of precision medicine. Precision oncology is one of the domains where data science promises to be particularly impactful. During this presentation, I will illustrate the use of clinical, molecular and imaging data to guide a precision oncology program, with a special focus on precision immuno-oncology. Extension of our local leman network to the Swiss network will be illustrated with the Swiss Personalized Oncology – National Data Stream (SPO-NDS) program from the Swiss Personalized Health Network (SPHN).
Prof. Olivier Michielin obtained a Masters of Physics in 1991 at the Swiss Federal Institute of Technology and a Medical Degree from the University of Lausanne in 1997. He pursued his PhD training under the supervision of Jean-Charles Cerottini (Ludwig Institute) and Martin Karplus (Harvard and Strasbourg Universities, Chemistry Nobel Prize Laureate 2013). He was appointed Group Leader of the Swiss Institute of Bioinformatics in 2002 and became an Assistant Professor at the Medical Faculty of Lausanne in 2004. In parallel, he has trained as a medical oncologist and obtained his board certification in 2007 at the Department of oncology of the Lausanne University Hospital. Prof. Olivier Michielin is mainly focused on translational and precision oncology, developing new molecularly defined therapeutic approaches based on original bioinformatics techniques developed in his laboratory, as well as precision oncology programs based on multi-omics strategies and data science at the national level. Prof. Olivier Michielin is currently the Chair of the Department of Oncology and the Precision Oncology Service at the Geneva University Hospital, the Head of the Precision Oncology Center of the Lausanne University Hospital and a co-Director of the Swiss Cancer Center Léman (SCCL).